CDKN2A and neoplasm: While more studies need to be conducted to investigate the further role of these genes in HNSCC, screening for circulating tumor DNA from peripheral blood using a panel of these genes may serve as an additional screening tool other than p16-IHC or HPV DNA detection for HPV-positive HNSCC.